BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26670365)

  • 1. Improvements in Topical Ocular Drug Delivery Systems: Hydrogels and Contact Lenses.
    Ribeiro AM; Figueiras A; Veiga F
    J Pharm Pharm Sci; 2015; 18(5):683-95. PubMed ID: 26670365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic drug delivery systems--recent advances.
    Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
    Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.
    Chaudhari P; Ghate VM; Lewis SA
    Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on therapeutic contact lenses for ocular drug delivery.
    Maulvi FA; Soni TG; Shah DO
    Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.
    Abdi B; Mofidfar M; Hassanpour F; Kirbas Cilingir E; Kalajahi SK; Milani PH; Ghanbarzadeh M; Fadel D; Barnett M; Ta CN; Leblanc RM; Chauhan A; Abbasi F
    Int J Pharm; 2023 May; 638():122740. PubMed ID: 36804524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic contact lenses: a patent review.
    Dixon P; Shafor C; Gause S; Hsu KH; Powell KC; Chauhan A
    Expert Opin Ther Pat; 2015; 25(10):1117-29. PubMed ID: 26143943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
    Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
    Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lenses as drug-delivery systems: a promising therapeutic tool.
    Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Topical Delivery of Chlorhexidine to the Cornea: Enhancement Using Drug-Loaded Contact Lenses and β-Cyclodextrin Complexation, and the Importance of Simulating Tear Irrigation.
    Hewitt MG; Morrison PWJ; Boostrom HM; Morgan SR; Fallon M; Lewis PN; Whitaker D; Brancale A; Varricchio C; Quantock AJ; Burton MJ; Heard CM
    Mol Pharm; 2020 Apr; 17(4):1428-1441. PubMed ID: 32125863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
    Hsu KH; Fentzke RC; Chauhan A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Trends in Advanced Contact Lenses.
    Mutlu Z; Shams Es-Haghi S; Cakmak M
    Adv Healthc Mater; 2019 May; 8(10):e1801390. PubMed ID: 30938941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of contact lens based ocular drug delivery systems for single-day use: Part (I) Structural factors, surrogate ophthalmic dyes and passive diffusion studies.
    Mahomed A; Tighe BJ
    J Biomater Appl; 2014 Sep; 29(3):341-53. PubMed ID: 24663443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
    Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.